Maciej Mrugala

2.9k total citations
19 papers, 441 citations indexed

About

Maciej Mrugala is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Maciej Mrugala has authored 19 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Maciej Mrugala's work include Glioma Diagnosis and Treatment (13 papers), Brain Metastases and Treatment (5 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Maciej Mrugala is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Brain Metastases and Treatment (5 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Maciej Mrugala collaborates with scholars based in United States, Australia and Portugal. Maciej Mrugala's co-authors include Jason K. Rockhill, Marc C. Chamberlain, Axel Thielscher, Zéev Bomzon, Cornelia Wenger, Pedro C. Miranda, Moshe Giladi, Ricardo Salvador, Anders Rosendal Korshoej and Brian C. Beard and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Maciej Mrugala

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maciej Mrugala United States 9 148 138 98 87 77 19 441
Takahiko Tsugawa Japan 13 112 0.8× 149 1.1× 168 1.7× 62 0.7× 102 1.3× 36 493
Ruichong Ma United Kingdom 15 179 1.2× 78 0.6× 91 0.9× 106 1.2× 56 0.7× 32 497
Yoshinori Tanizaki Japan 14 241 1.6× 101 0.7× 80 0.8× 149 1.7× 45 0.6× 20 473
Yoshiteru Miyajima Japan 11 238 1.6× 105 0.8× 70 0.7× 70 0.8× 37 0.5× 22 415
Junya Yamaguchi Japan 10 116 0.8× 63 0.5× 43 0.4× 102 1.2× 50 0.6× 50 318
Zachary R. Barnard United States 11 145 1.0× 82 0.6× 126 1.3× 132 1.5× 236 3.1× 28 559
Jonathan B. Lamano United States 14 258 1.7× 107 0.8× 99 1.0× 135 1.6× 223 2.9× 23 653
Fares Nigim United States 12 91 0.6× 74 0.5× 67 0.7× 102 1.2× 93 1.2× 17 356
Ryan Mathew United Kingdom 11 158 1.1× 35 0.3× 69 0.7× 89 1.0× 95 1.2× 42 405
Rutger K. Balvers Netherlands 11 188 1.3× 47 0.3× 50 0.5× 149 1.7× 102 1.3× 26 434

Countries citing papers authored by Maciej Mrugala

Since Specialization
Citations

This map shows the geographic impact of Maciej Mrugala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Mrugala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Mrugala more than expected).

Fields of papers citing papers by Maciej Mrugala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Mrugala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Mrugala. The network helps show where Maciej Mrugala may publish in the future.

Co-authorship network of co-authors of Maciej Mrugala

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Mrugala. A scholar is included among the top collaborators of Maciej Mrugala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Mrugala. Maciej Mrugala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dmello, Crismita, Andrew Brenner, David Piccioni, et al.. (2024). Phase II trial of blood–brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma. Neuro-Oncology Advances. 6(1). vdae186–vdae186. 6 indexed citations
2.
Strowd, Roy E., Erin Dunbar, Hui Gan, et al.. (2022). Practical guidance for telemedicine use in neuro-oncology. Neuro-Oncology Practice. 9(2). 91–104. 8 indexed citations
3.
Sharma, Akanksha, Briant Fruth, Maciej Mrugala, et al.. (2021). How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians. Journal of Neuro-Oncology. 152(2). 313–323. 15 indexed citations
4.
Butterfield, Richard, Nan Zhang, Piotr Złomańczuk, et al.. (2020). Does location matter? Characterisation of the anatomic locations, molecular profiles, and clinical features of gliomas. Neurologia i Neurochirurgia Polska. 54(5). 456–465. 4 indexed citations
5.
Mrugala, Maciej, Bryan Kim, Akanksha Sharma, et al.. (2019). Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer. Clinical Breast Cancer. 19(5). 311–316. 31 indexed citations
6.
Johnston, Sandra K., et al.. (2018). PATH-12. CHARACTERISTICS OF GIANT CELL MORPHOLOGY IN LONG-TERM SURVIVORS OF GLIOBLASTOMA: CONSIDERATION OF SEX DIFFERENCES. Neuro-Oncology. 20(suppl_6). vi160–vi160. 1 indexed citations
7.
Wenger, Cornelia, Pedro C. Miranda, Ricardo Salvador, et al.. (2018). A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling. IEEE Reviews in Biomedical Engineering. 11. 195–207. 85 indexed citations
8.
Porter, Alyx B., Terence T. Sio, Kent D. Nelson, et al.. (2018). Disseminated High-grade Glioma in a Long-term Survivor of Medulloblastoma. The Neurologist. 23(6). 191–193. 2 indexed citations
9.
Sharma, Akanksha, Justin Low, & Maciej Mrugala. (2018). Neuro-oncologists have spoken – the role of bevacizumab in the inpatient setting. A clinical and economic conundrum. Neuro-Oncology Practice. 6(1). 30–36. 12 indexed citations
10.
Kumthekar, Priya, Vaibhav G. Patel, Carly A. Bridge, et al.. (2017). Prognosis of older patients with low-grade glioma: A retrospective study. PubMed. 4(5). 3 indexed citations
11.
Elinzano, Heinrich, Michael Glantz, Maciej Mrugala, et al.. (2015). PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation. American Journal of Clinical Oncology. 41(2). 159–162. 16 indexed citations
12.
Wong, Eric T., Herbert H. Engelhard, David Tran, et al.. (2014). NovoTTF-100A alternating electric fields therapy for recurrent glioblastoma: An analysis of patient registry data.. Journal of Clinical Oncology. 32(15_suppl). e13033–e13033. 1 indexed citations
13.
Neal, Maxwell L., Andrew D. Trister, Sunyoung Ahn, et al.. (2013). Response Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from Pseudoprogression. Cancer Research. 73(10). 2976–2986. 49 indexed citations
14.
Adair, Jennifer E., Brian C. Beard, Grant D. Trobridge, et al.. (2012). Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy. Science Translational Medicine. 4(133). 133ra57–133ra57. 75 indexed citations
15.
Adair, Jennifer E., Brian C. Beard, Grant D. Trobridge, et al.. (2011). Integration-Mediated Activation of PRDM16 and HMGA2 in Multiple Clones without Adverse Hematopoietic Consequences Following Transplant of Autologous MGMTP140K Gene-Modified CD34+ Cells. Blood. 118(21). 2053–2053. 1 indexed citations
16.
Nabors, Burt, S. Rosenfeld, Marc C. Chamberlain, et al.. (2009). A phase I evaluation of intravenous TM601 in recurrent glioblastoma: Use of perfusion MRI to monitor antiangiogenic effects. Journal of Clinical Oncology. 27(15_suppl). 2041–2041. 1 indexed citations
17.
Spence, Alexander M., Mark Muzi, Maciej Mrugala, et al.. (2007). [F-18]-fluoromisonidazole (FMISO) PET demonstrates reduced hypoxia in recurrent malignant gliomas that respond to bevacizumab and irinotecan. Molecular Cancer Therapeutics. 6. 1 indexed citations
18.
Rockhill, Jason K., Maciej Mrugala, & Marc C. Chamberlain. (2007). Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurgical FOCUS. 23(4). E1–E1. 116 indexed citations
19.
Rockhill, Jason K., Maciej Mrugala, & Marc C. Chamberlain. (2007). Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurgical FOCUS. 23(4). E1–E1. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiko Tsugawa Breakdown of academic impact, for papers by Ruichong Ma Breakdown of academic impact, for papers by Yoshinori Tanizaki Breakdown of academic impact, for papers by Yoshiteru Miyajima Breakdown of academic impact, for papers by Junya Yamaguchi Breakdown of academic impact, for papers by Zachary R. Barnard Breakdown of academic impact, for papers by Jonathan B. Lamano Breakdown of academic impact, for papers by Fares Nigim Breakdown of academic impact, for papers by Ryan Mathew Breakdown of academic impact, for papers by Rutger K. Balvers
Rankless by CCL
2026